Elicio Therapeutics, Inc. (ELTX)
NASDAQ: ELTX · Real-Time Price · USD
12.53
+1.04 (9.05%)
At close: Jun 3, 2026, 4:00 PM EDT
12.56
+0.03 (0.24%)
After-hours: Jun 3, 2026, 4:31 PM EDT
Elicio Therapeutics Stock Forecast
Stock Price Forecast
The 4 analysts that cover Elicio Therapeutics stock have a consensus rating of "Buy" and an average price target of $18, which forecasts a 43.66% increase in the stock price over the next year. The lowest target is $17 and the highest is $20.
Price Target: $18 (+43.66%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Elicio Therapeutics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 2 | 2 | 1 | 3 | 4 | 4 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 1 | 3 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $17 | Buy | Reiterates | $17 | +35.67% | May 28, 2026 |
| JonesTrading | JonesTrading | Buy Maintains $18 | Buy | Maintains | $18 | +43.66% | May 12, 2026 |
| Ladenburg Thalmann & Co. | Ladenburg Thalmann & Co. | Buy Initiates $20 | Buy | Initiates | $20 | +59.62% | Apr 15, 2026 |
| Rodman & Renshaw | Rodman & Renshaw | Buy Initiates $17 | Buy | Initiates | $17 | +35.67% | Mar 9, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-1.90
from -2.58
EPS Next Year
-1.80
from -1.90
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | n/a | n/a | |
| Avg | n/a | n/a | |
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -1.79 | -1.85 | |
| Avg | -1.90 | -1.80 | |
| Low | -1.98 | -1.72 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and consensus ratings provided by TipRanks. Historical ratings and analyst data provided by TipRanks. Financial forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.